<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To examine the natural history of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> with routinely diagnosed low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and ascertain the risk of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> development </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: A multicentre retrospective cohort study of 283 patients with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Follow-up data were obtained from examination of hospital records </plain></SENT>
<SENT sid="3" pm="."><plain>One hundred and forty-four patients had biopsies prior to low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> diagnosis and 217 had follow-up biopsies after index low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>In these patients the incidence of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> combined was 4.6% per annum and of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> alone was 2.7% per annum </plain></SENT>
<SENT sid="5" pm="."><plain>At most recent follow-up, 43 (19.8%) had persistent low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 37 (17.1%) had changes indefinite for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 108 (49.8%) had non-dysplastic <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>When prevalent cases were excluded (those occurring within 1 year of index low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> diagnosis), the annual incidence of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> combined was 2.2% and of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> alone was 1.4% </plain></SENT>
<SENT sid="7" pm="."><plain>The relative risk for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> development in low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> compared with non-dysplastic <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> was 2.871 (P = 0.002) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> has a threefold increased risk of progression to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> compared with non-dysplastic epithelium, but in the majority of patients <z:mpath ids='MPATH_589'>dysplasia</z:mpath> is not subsequently detected </plain></SENT>
</text></document>